Item List

Strados Labs, the respiratory endpoint intelligence company, today announced the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados' suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) - complementing its existing technologies for cough monitoring and lung sound monitoring to create a unique end-to-end offering for Phase I through Phase IV respiratory trials.